{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:33:01Z","timestamp":1760783581868},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FEMS Yeast Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/j.1567-1364.2012.00838.x","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T11:25:06Z","timestamp":1344425106000},"page":"890-896","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C.\u00a0tropicalis bloodstream isolates from eleven"],"prefix":"10.1093","volume":"12","author":[{"given":"Sonia U.","family":"Purisco","sequence":"first","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena A.","family":"Martins","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria W.","family":"Szeszs","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulcilena M.","family":"Castro e Silva","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra R.B.S.","family":"Pukinskas","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas X.","family":"Bonfietti","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres A.","family":"Baez","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia S.C.","family":"Melhem","sequence":"additional","affiliation":[{"name":"Adolfo Lutz Institute; Coordination of Disease Control; Secretary of Health; Government of S\u00e3o Paulo State; S\u00e3o Paulo; Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,9,14]]},"reference":[{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0001|fyr838-cit-0001","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0002|fyr838-cit-0002","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/AAC.01624-08","article-title":"Breakpoints for susceptibility testing should not divide wild-type distributions of important target species","volume":"53","author":"Arendrup","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0003|fyr838-cit-0003","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/00365540410021126","article-title":"Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality","volume":"36","author":"Bader","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0004|fyr838-cit-0004","first-page":"1","article-title":"Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital","volume":"3","author":"Bruder-Nascimento","year":"2010","journal-title":"BioMed Central"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0005|fyr838-cit-0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/00365540902777105","article-title":"Recent experience with fungaemia: change in species distribution and azole resistance","volume":"41","author":"Chakrabarti","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0006|fyr838-cit-0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/S0036-46652008000500003","article-title":"Candida bloodstream infection: data from a teaching hospital in Mato Grosso do Sul, Brazil","volume":"50","author":"Chang","year":"2008","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0007|fyr838-cit-0007","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.diagmicrobio.2010.07.004","article-title":"Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan","volume":"68","author":"Chen","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0009|fyr838-cit-0009","volume-title":"Centro de Vigil\u00e2ncia Epidemiol\u00f3gica","author":"CVE","year":"2010"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0010|fyr838-cit-0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.diagmicrobio.2006.10.011","article-title":"Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in S\u00e3o Paulo, Brazil, 1995-2003","volume":"57","author":"Matta","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0011|fyr838-cit-0011","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2010.03302.x","article-title":"Characterization of Candida parapsilosis complex isolates","volume":"17","author":"Toro","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0012|fyr838-cit-0012","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","article-title":"Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study","volume":"40","author":"Diekema","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0013|fyr838-cit-0013","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JCM.00942-09","article-title":"In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods","volume":"47","author":"Diekema","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0014|fyr838-cit-0014","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosupressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0015|fyr838-cit-0015","volume-title":"Amphotericin B: Rationale for the Clinical Breakpoints","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2010"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0016|fyr838-cit-0016","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/01.CCM.0000171537.03493.B0","article-title":"Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study","volume":"33","author":"Fourrier","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0017|fyr838-cit-0017","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0074-02762003000300020","article-title":"Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American Hospitals","volume":"98","author":"Godoy","year":"2003","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0018|fyr838-cit-0018","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1128\/AAC.01595-07","article-title":"Prevalence and susceptibility profile Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain","volume":"52","author":"Gomez-Lopez","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0019|fyr838-cit-0019","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1469-0691.2009.03020.x","article-title":"Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil","volume":"16","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0020|fyr838-cit-0020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0021|fyr838-cit-0021","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0022|fyr838-cit-0022","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JCM.00803-08","article-title":"Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis","volume":"46","author":"Lockhart","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0023|fyr838-cit-0023","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/JCM.40.8.2860-2865.2002","article-title":"Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR","volume":"40","author":"Luo","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0024|fyr838-cit-0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0036-46652006000100004","article-title":"Candidemia in a Brazilian hospital: the importance of Candida parapsilosis","volume":"48","author":"Medrano","year":"2006","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0025|fyr838-cit-0025","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/JCM.02434-08","article-title":"Activity of contemporary agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)","volume":"47","author":"Messer","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0026|fyr838-cit-0026","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/jac\/dkr298","article-title":"Prevalence and antifungal susceptibility patterns of new crypto-species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital","volume":"66","author":"Miranda-Zapico","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0027|fyr838-cit-0027","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","article-title":"Multiechinocandin and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis","volume":"49","author":"Moudgal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0028|fyr838-cit-0028","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10156-006-0438-Y","article-title":"Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia","volume":"12","author":"Nakamura","year":"2006","journal-title":"J Infect Chemother"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0030|fyr838-cit-0030","first-page":"3145","article-title":"Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital","volume":"163","author":"Passos","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0031|fyr838-cit-0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diagmicrobio.2004.12.010","article-title":"Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines","volume":"52","author":"Patel","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0032|fyr838-cit-0032","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/13693780903580121","article-title":"Five-year evaluation of bloodstream yeast infection in a tertiary hospital: The predominance of non-C.\u00a0albicans Candida species","volume":"48","author":"Pereira","year":"2010","journal-title":"Med Mycol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0033|fyr838-cit-0033","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0034|fyr838-cit-0034","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.42.7.3142-3146.2004","article-title":"Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0036|fyr838-cit-0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of non-Candida yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"47","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0037|fyr838-cit-0037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","article-title":"Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)","volume":"38","author":"Pfaller","year":"2011a","journal-title":"J Antimicrob Agents"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0038|fyr838-cit-0038","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011b","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0035|fyr838-cit-0035","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JCM.02432-10","article-title":"Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates","volume":"49","author":"Pfaller","year":"2011c","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0040|fyr838-cit-0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/2047-783X-16-4-187","article-title":"Epidemiology and antifungal resistance in invasive candidiasis","volume":"16","author":"Rodloff","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0041|fyr838-cit-0041","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1469-0691.2007.01892.x","article-title":"Candida glabrata fungaemia in intensive care units","volume":"14","author":"Ruan","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0042|fyr838-cit-0042","volume-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989","edition":"2"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0043|fyr838-cit-0043","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11046-010-9278-5","article-title":"Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria","volume":"169","author":"Savini","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0044|fyr838-cit-0044","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11908-006-0016-6","article-title":"The emergence of non-albicansCandida species as causes of invasive candidiasis and candidemia","volume":"8","author":"Sobel","year":"2006","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0045|fyr838-cit-0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-0691.2008.02087.x","article-title":"EUCAST Technical note on voriconazole","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing","year":"2008a","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0046|fyr838-cit-0046","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1469-0691.2007.01899.x","article-title":"EUCAST technical note on fluconazole","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing","year":"2008b","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0047|fyr838-cit-0047","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing","year":"2008c","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0048|fyr838-cit-0048","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JCM.43.1.284-292.2005","article-title":"Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III","volume":"43","author":"Tavanti","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0049|fyr838-cit-0049","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1099\/jmm.0.004242-0","article-title":"Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections","volume":"58","author":"Tay","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0050|fyr838-cit-0050","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1439-0507.1999.00497.x","article-title":"Case report. Osteomyelitis caused by high resistant Candida guilliermondii","volume":"42","author":"Tiez","year":"1999","journal-title":"Mycoses"},{"key":"10.1111\/j.1567-1364.2012.00838.x-BIB0051|fyr838-cit-0051","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["FEMS Yeast Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsyr\/article-pdf\/12\/8\/890\/18113001\/12-8-890.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T16:47:43Z","timestamp":1562086063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsyr\/article-lookup\/doi\/10.1111\/j.1567-1364.2012.00838.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,14]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1567-1364.2012.00838.x","relation":{},"ISSN":["1567-1356"],"issn-type":[{"value":"1567-1356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,14]]}}}